NCT03713801View on ClinicalTrials.gov

Impact of Metformin on Immunity

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

July 16, 2024

Study Completion Date

July 16, 2024

Conditions
AgingVaccine Response Impaired
Interventions
DRUG

Metformin

Total daily dose titrated up to 1500 mg po q day over the course of 3 weeks and continued for a total exposure of 12 weeks.

DRUG

Placebo

Placebo tablets titrated up to 3 tablets over the course of 3 weeks and then continued as 3 daily for a total exposure of 12 weeks

Trial Locations (1)

78229

UT Health San Antonio, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT03713801 - Impact of Metformin on Immunity | Biotech Hunter | Biotech Hunter